Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / ADR
-
Shares outstanding
-
55,574,229
-
Number of holders
-
245
-
Total 13F shares, excl. options
-
62,895,390
-
Shares change
-
-2,307,564
-
Total reported value, excl. options
-
$10,855,906,781
-
Value change
-
-$373,773,069
-
Put/Call ratio
-
32.7%
-
Number of buys
-
124
-
Number of sells
-
-127
-
Price
-
$172.6
Significant Holders of Ascendis Pharma A/S - ADR (ASND) as of Q2 2025
303 filings reported holding ASND - Ascendis Pharma A/S - ADR as of Q2 2025.
Ascendis Pharma A/S - ADR (ASND) has 245 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 62,895,390 shares
.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (10,281,496 shares), WESTFIELD CAPITAL MANAGEMENT CO LP (5,451,401 shares), Avoro Capital Advisors LLC (4,980,000 shares), FMR LLC (4,531,724 shares), JANUS HENDERSON GROUP PLC (4,427,792 shares), Artisan Partners Limited Partnership (3,990,424 shares), T. Rowe Price Investment Management, Inc. (3,583,546 shares), Capital International Investors (3,046,931 shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (1,901,843 shares), and PRICE T ROWE ASSOCIATES INC /MD/ (1,875,491 shares).
This table shows the top 245 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.